Von Hippel–Lindau disease

 Von Hippel–Lindau disease (VHL) disease results from a mutation in the von Hippel–Lindau tumor suppressor gene on chromosome 3p25.3.                   a rare genetic disease that is characterized by hemangiomas of the retina and cerebellum and often by cysts or tumors of the liver, pancreas, and kidneys and that is typically inherited as an autosomal dominant trait—called also Lindau's disease.

Sometimes von Hippel Lindau disease has no symptoms. When it does have signs, they vary from person to person and depend on the problems caused by the disease. These symptoms usually do not mean you have VHL. However, it is important to discuss any symptoms with your doctor, since they may signal other health problems.

What is the prognosis?

The prognosis for patients with VHL depends on the location and complications of the tumors. Untreated, VHL may result in blindness and/or permanent brain damage. With early detection and treatment the prognosis is significantly improved. Death is usually caused by complications of brain tumors or kidney cancer.Treatment

Cap AVH (1 Cap Every 6 Hours)

Syp AVH  (2Teasponful Every 6 Hours)